Free Republic
Browse · Search
General/Chat
Topics · Post Article

Skip to comments.

Study among first to show drugs targeting the lung, rather than bacteria, may prevent staph infection in flu patients (Ivacaftor)
Medical Xpress / The Mount Sinai Hospital / Journal of Clinical Investigation ^ | Aug. 15, 2023 | Stephanie Tang et al

Posted on 08/17/2023 6:44:24 PM PDT by ConservativeMind

Influenza infection (flu) is a major cause of death around the world. People who die of the flu often have a secondary lung infection with Staphylococcus aureus (staph) bacteria that starts a few days after flu infection begins. A team studied how the flu paves the way for staph infection in the lungs. The researchers found that healthy lungs secrete liquid into their air sacs that prevents a staph infection. The flu blocks this liquid secretion by inhibiting a protein called CFTR, making it possible for staph that are inhaled into the air sacs to stick to the air sac walls, initiate infection, and damage the lungs. Treatment with a CFTR-activating drug, such as ivacaftor, restores liquid secretion in air sacs of the flu-infected lungs and restores the air sacs' natural protection against staph infection.

Researchers say these findings support trials that test whether ivacaftor can prevent secondary staph infection in people with the flu, which is highly feasible since the medication is already in clinical use for both children and adults.

Jaime Hook, MD said, "The combination of flu and staph infections in the lungs is deadly. Antibiotics don't always resolve the staph infection because they might be started after the infection is already severe and it's too late to treat it, or because the antibiotics don't work. Our work shows how drugs that target the lung—rather than the bacteria—might treat staph infection in flu-infected lungs. We think that drugs that activate the CFTR protein, like ivacaftor, rescue a critical lung defense mechanism in flu-infected lungs to restore the lung's natural protection against staph infection. In this way, giving CFTR activator drugs to people with the flu who are at risk for a secondary staph infection might prevent staph infection from initiating, thereby preventing death from flu-staph coinfection."

(Excerpt) Read more at medicalxpress.com ...


TOPICS: Health/Medicine
KEYWORDS: ivacaftor; lungs
Ivacaftor is available today, but would be administered at the hospital.
1 posted on 08/17/2023 6:44:24 PM PDT by ConservativeMind
[ Post Reply | Private Reply | View Replies]

To: Mazey; ckilmer; goodnesswins; Jane Long; BusterDog; jy8z; ProtectOurFreedom; matthew fuller; ...

The “Take Charge Of Your Health” Ping List

This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

2 posted on 08/17/2023 6:45:11 PM PDT by ConservativeMind (Trump: Befuddling Democrats, Republicans, and the Media for the benefit of the US and all mankind.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: ConservativeMind

That’s very cool!


3 posted on 08/17/2023 6:54:57 PM PDT by MarMema (Eat your bananas, enjoy the decline)
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
General/Chat
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson